Nadolol
- Product NDC
- 23155-731
- 11-digit product format
- 231550731
- Labeler code
- 23155
- Product ID
- 23155-731_7ce5fe0a-cf3d-4ef6-892c-b737f87c33e1
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Nadolol
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
- Application
- ANDA074229
- Marketing category
- ANDA
- Marketing start
- 2020-07-10
- Marketing end
- 0000-00-00
- Substance
- NADOLOL
- Active strength
- 40 mg/1
- Pharmacologic classes
- Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 23155-731-01 | 23155073101 | 100 TABLET in 1 BOTTLE (23155-731-01) | 100 tablet | 2020-07-10 | 0000-00-00 | No | No | Current |
| 23155-731-09 | 23155073109 | 90 TABLET in 1 BOTTLE (23155-731-09) | 90 tablet | 2021-02-26 | 0000-00-00 | No | No | Current |
| 23155-731-10 | 23155073110 | 1000 TABLET in 1 BOTTLE (23155-731-10) | 1000 tablet | 2021-02-26 | 0000-00-00 | No | No | Current |